Evidence map›Paper›PMID 14654999›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2004

Xanthine nucleotide-specific G-protein alpha-subunits: a novel approach for the analysis of G-protein-mediated signal transduction.

Andreas Gille, Roland Seifert

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andreas GilleDepartment of Pharmacology and Toxicology, The University of Kansas, 1251 Wescoe Hall Drive, Malott Hall, Room 5064, Lawrence, KS 66045-7582, USA.
Roland Seifert
University of Kansas · US

Funding

WEIGHT CONTROL, CELL SIGNALING AND CANCER PREVENTIONP20RR015563 · NCRR · UNIVERSITY OF KANSAS LAWRENCE · PI ZUFFEREY, RACHEL · 2000 to 2009
$20.1M
NCRR NIH HHS 1 P20 RR 15563
6 · The paper itself

Abstract

Pro- and eukaryotic cells express multiple GTP-binding proteins that play crucial roles in signal transduction. GTP-binding proteins possess a highly conserved NKX D motif critically involved in guanine binding. In order to selectively activate a defined GTP-binding protein, base-specificity can be switched from guanine to xanthine by mutating the conserved aspartate into asparagine (D/N-mutation). This approach was very successful at elucidating the function of structurally diverse GTP-binding proteins in complex systems. However, attempts to generate functional xanthine nucleotide-specific alpha-subunits of heterotrimeric GTP-binding proteins (G-proteins) met more difficulties. Recent studies have shown that a sufficiently high GDP-affinity is critical for functional expression of xanthine nucleotide-selective G-protein mutants. Moreover, xanthosine 5'-[gamma-thio]triphosphate and xanthosine 5'-[gamma, beta-imido]triphosphate are not functionally equivalent activators of D/N-G-protein mutants. We are now in the position to exploit xanthine nucleotide-specific G-proteins to dissect signaling pathways activated by a given G-protein in complex systems.

Indexed as

AnimalsGTP-Binding Protein alpha SubunitsGTP-Binding ProteinsMutationPurine NucleotidesSignal TransductionXanthinesGTP-Binding Protein alpha SubunitsGTP-Binding ProteinsPurine NucleotidesXanthines

Identifiers

PMID14654999
OpenAlexW2059001558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.